AAVXF
Price
$96.71
Change
+$5.51 (+6.04%)
Updated
Oct 10 closing price
Capitalization
7.41B
Intraday Buy/Sell Signals
PEPG
Price
$4.58
Change
+$0.03 (+0.66%)
Updated
Oct 14 closing price
Capitalization
315.5M
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

AAVXF vs PEPG

Header iconAAVXF vs PEPG Comparison
Open Charts AAVXF vs PEPGBanner chart's image
Abivax SA
Price$96.71
Change+$5.51 (+6.04%)
Volume$10.1K
Capitalization7.41B
PepGen
Price$4.58
Change+$0.03 (+0.66%)
Volume$1.35M
Capitalization315.5M
AAVXF vs PEPG Comparison Chart in %
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. PEPG commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and PEPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (AAVXF: $96.71 vs. PEPG: $4.58)
Brand notoriety: AAVXF and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 1215% vs. PEPG: 36%
Market capitalization -- AAVXF: $7.41B vs. PEPG: $315.5M
AAVXF [@Biotechnology] is valued at $7.41B. PEPG’s [@Biotechnology] market capitalization is $315.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 1 FA rating(s) are green whilePEPG’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 1 green, 4 red.
  • PEPG’s FA Score: 0 green, 5 red.
According to our system of comparison, AAVXF is a better buy in the long-term than PEPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 2 TA indicator(s) are bullish while PEPG’s TA Score has 7 bullish TA indicator(s).

  • AAVXF’s TA Score: 2 bullish, 4 bearish.
  • PEPG’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than AAVXF.

Price Growth

AAVXF (@Biotechnology) experienced а +12.32% price change this week, while PEPG (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

PEPG is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($7.41B) has a higher market cap than PEPG($316M). AAVXF YTD gains are higher at: 775.204 vs. PEPG (20.844). PEPG has higher annual earnings (EBITDA): -97.54M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. PEPG (74.7M). PEPG has less debt than AAVXF: PEPG (17.9M) vs AAVXF (92.6M). AAVXF (0) and PEPG (0) have equivalent revenues.
AAVXFPEPGAAVXF / PEPG
Capitalization7.41B316M2,346%
EBITDA-170.04M-97.54M174%
Gain YTD775.20420.8443,719%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M74.7M139%
Total Debt92.6M17.9M517%
FUNDAMENTALS RATINGS
AAVXF: Fundamental Ratings
AAVXF
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFPEPG
RSI
ODDS (%)
Bearish Trend 8 days ago
54%
Bearish Trend 8 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
46%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
43%
Bullish Trend 10 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 10 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
32%
Bullish Trend 8 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
35%
Bullish Trend 8 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
86%
Declines
ODDS (%)
Bearish Trend about 1 month ago
67%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 9 days ago
47%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
41%
Bullish Trend 8 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASXFF39.50N/A
N/A
ASX, Ltd.
CKNHF47.41N/A
N/A
Clarkson Horace Plc
NNFSF6.89N/A
N/A
NONGFU SPRING CO LTD.
LOVFF1.25N/A
-0.04%
Cannara Biotech Inc.
TINFF0.17-0.01
-6.11%
Tincorp Metals Inc.

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
SRPT - AAVXF
45%
Loosely correlated
-2.41%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
+1.59%
PEPG - AAVXF
23%
Poorly correlated
+0.66%
More

PEPG and

Correlation & Price change

A.I.dvisor tells us that PEPG and TRDA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PEPG and TRDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+0.66%
TRDA - PEPG
30%
Poorly correlated
+4.30%
FENC - PEPG
30%
Poorly correlated
-1.95%
ABOS - PEPG
29%
Poorly correlated
+9.91%
SLDB - PEPG
29%
Poorly correlated
+3.66%
LEXX - PEPG
29%
Poorly correlated
-3.21%
More